Figure 5From: Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure Potential therapeutic use of B1 and B2 kinin receptors (B1R, B2R) modulators to prevent anthracycline-induced myocardial damage. Back to article page